EN
HI
Summary
As of 10 Nov, 2026, Biofil Chemicals & Pharmaceuticals stock price is ₹30.51. During the trading session, the stock has moved between an intraday low of ₹30.26 and an intraday high of ₹31.60. Over the last 52 weeks, Biofil Chemicals & Pharmaceuticals has traded between ₹25.60 and ₹46.34.
The stock has recorded a trading volume of 3,677 shares,. Its Average Traded Price (ATP) is ₹30.80, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 40 @ ₹30.51.
Biofil Chemicals & Pharmaceuticals has an upper circuit limit of ₹37.11 and a lower circuit limit of ₹24.75. The total value traded stands at ₹1.13 L, and the delivery percentage for the day is 65.39%.
The stock is currently traded with a market lot size of 1. Biofil Chemicals & Pharmaceuticals also offers a dividend yield of 0%.
Biofil Chemicals & Pharmaceuticals Share Price Chart
Biofil Chemicals & Pharmaceuticals Share Key Metrics
Volume
3677.00
Market Cap
49.65 CR
LTQ@LTP
40@30.51
ATP
30.8
Var Margin
25 %
Circuit Range
24.75-37.11
Delivery %
65.39 %
Value
1.13 L
ASM/GSM
No
Market Lot
1
Biofil Chemicals & Pharmaceuticals Resistance and Support
Pivot 30.93
Resistance
First Resistance
31.55
Second Resistance
32.17
Third Resistance
32.79
Support
First Support
30.31
Second Support
29.69
Third Support
29.07
Biofil Chemicals & Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 31.6 | 30.51 | -1.36% | 31.6 | 30.26 |
| Sun Nov 08 2026 | 31.5 | 30.93 | 0.52% | 31.54 | 30.3 |
| Fri Nov 06 2026 | 30.22 | 30.77 | 1.82% | 31.11 | 30.22 |
Biofil Chemicals & Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-14 | Quarterly Results |
| 2026-08-11 | Quarterly Results |
| 2026-05-30 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-11 | Quarterly Results & Others |
| 2024-11-14 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Biofil Chemicals & Pharmaceuticals News
Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Board Meeting Intimation for For Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September, 2026 Along With Limited Review Report Thereon.
Biofil Chemicals board of directors will meet on 14 November 2026. The primary agenda is to review and approve the financial results for Q2 FY27.
Nov 03 2026 13:45:15
Biofil Chemicals & Pharmaceuticals Management
| Name | Position |
|---|---|
| Apoorv Jain | Company Secretary & Compliance Officer |
| Ketan Shah | Chairman & Managing Director |
Biofil Chemicals & Pharmaceuticals Similar Stocks
Biofil Chemicals & Pharmaceuticals FAQs
The Buying Price of Biofil Chemicals & Pharmaceuticals share is 30.51 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Biofil Chemicals & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biofil Chemicals & Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Biofil Chemicals & Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Biofil Chemicals & Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Biofil Chemicals & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 62.39 & 1.75 with sector averages, along with growth rates and financial metrics.
The Market Cap of Biofil Chemicals & Pharmaceuticals is 49.65 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Biofil Chemicals & Pharmaceuticals share price is 46.34 & 25.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Biofil Chemicals & Pharmaceuticals belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BIOFILCHEM
Or Download Choice FinX App
Invest in BIOFILCHEM
